Per most recent ANN OncoSil seems to think study recruitment will take approx. 2 years.
I agree with you Cafa, initial 20 patient FDA safety run in might not even meet this, ahem, timeline.
Also, per ANN, OncoSil expects 1st patient enrolment in 2017. That's 5 months from now. Seems like a long time, appreciating the complexities of recruiting a patient satisfying all inclusion/exclusion criteria. Perhaps issues getting sites on board / IRB approvals and / or issues with manufacturing? Who will ever really know. Either way seems slack ...
Per most recent ANN OncoSil seems to think study recruitment...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.075(6.10%) |
Mkt cap ! $16.35M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.25 | $1.11 | $45.47K | 37.73K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16450 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 585 | 1 |
View Market Depth
| Last trade - 14.02pm 27/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |